The Exchange has received Disclosure under Regulation 31 (1) and 31 (2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 02, 2025 for G Madhukar Reddy & Lone Furrow ...

Forecast: Pharma and healthcare mutual funds have topped with an average return of 38.05% in 2024. HDFC Pharma and Healthcare ...

Disclosure under Regulation 31(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 ...

MedPlus Health Services Limited was incorporated as a Private Limited Company with the name MedPlus Health Services Private Limited at Hyderabad on 30 November, 2006. The Company converted from a ...

The MedPlus is highly recognised and trusted brand for its integrity and the benefits it offers to the buyers. MedPlus runs a network of stores in over 12 states and across 150 cities and with 1350 ...

India pharma companies’ progress in complex generics, stable US pricing and steady sales growth in India led to fund houses buying into stocks like Alembic Pharma, Divis Labs, Glenmark, Medplus, ...

Stocks to Buy Today, Hot Stocks on December 13, 2024: Shares of several companies including IndusInd Bank, Tata Steel, Balrampur Chini Mills etc, will be in focus today on December 13 (Friday ...

Medplus Health Services Ltd - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31 (1) read with Regulation 28 (3) of SEBI (SAST) Regulations, 2011.

Medplus Health Services Ltd., incorporated in the year 2006, is a Large Cap company (having a market cap of Rs 9,699.46 Crore) operating in Retail sector. Medplus Health Services Ltd. key ...

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex, Nifty, stock market today, IPO news, mutual funds, and more on Business Standard.

Franklin Templeton MF, Invesco India, and Kotak Small Cap Fund acquired a 6% stake in Medplus at an average price of Rs 700 per share, totaling Rs 502.23 crore. Meanwhile, PI Opportunities Fund ...